CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States, NeuroOncol, vol.17, issue.4, pp.1-62, 2008. ,
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications, Acta Neuropathol, vol.128, pp.573-581, 2014. ,
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma, Nature, vol.482, pp.226-231, 2012. ,
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas, Nat Genet, vol.44, pp.251-253, 2012. ,
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes, Acta Neuropathol, vol.130, pp.815-827, 2015. ,
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas, Acta Neuropathol, vol.124, pp.439-447, 2012. ,
Diffuse midline gliomas with histone H3K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations, Brain Pathol, vol.26, pp.569-580, 2016. ,
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma, Cancer Cell, vol.22, pp.425-437, 2012. ,
Histone H3.3 mutations drive pediatric glioblastoma through upregulation of MYCN, Cancer Discov, vol.3, pp.512-519, 2013. ,
The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, vol.131, pp.803-820, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01479018
Incidence of gliomas by anatomic location, Neuro-Oncol, vol.9, pp.319-325, 2007. ,
H3F3A K27M mutations in thalamic gliomas from young adult patients, Neuro-Oncol, vol.16, pp.140-146, 2014. ,
The H3. 3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults, Hum Pathol, vol.46, pp.1626-1632, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01867135
Characteristics of H3 K27M-mutant gliomas in adults, Neuro-Oncol, vol.19, pp.1127-1134, 2017. ,
Molecular analysis of diffuse intrinsic brainstem gliomas in adults, J Neurooncol, vol.116, pp.405-411, 2014. ,
Targeting FGFR signaling in cancer, Clin Cancer Res, vol.21, pp.2684-2694, 2015. ,
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives, J Blood Med, vol.7, pp.171-180, 2016. ,
Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma, Acta Neuropathol Commun, vol.4, p.93, 2016. ,
Exome sequencing identifies somatic gain-offunction PPM1D mutations in brainstem gliomas, Nat Genet, vol.46, pp.726-730, 2014. ,
Laigle-Donadey F. Adult brainstem gliomas, Oncologist, vol.17, pp.388-397, 2012. ,
, Available at: wiki.cancerimagingarchive.net/ display/Public/VASARI+Research+Project, VASARI Research Project: the Cancer Imaging Archive (TCIA) Public Access: Cancer Imaging Archive Wiki, 2018.
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes, Neurology, vol.83, pp.1200-1206, 2014. ,
Chromosome 17p Homodisomy is associated with better outcome in 1p19q non-codeleted and IDH-mutated gliomas, Oncologist, vol.21, pp.1131-1135, 2016. ,
Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas, Brain Pathol, vol.27, pp.567-579, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01395265
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma, Acta Neuropathol, vol.129, pp.133-146, 2015. ,
Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors, Brain Pathol, vol.20, pp.245-254, 2010. ,
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas, Acta Neuropathol, vol.128, pp.743-753, 2014. ,
, Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, vol.455, pp.1061-1068, 2008.
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma, Cell, vol.164, pp.550-563, 2016. ,
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis, Neuro-Oncol, vol.6, pp.227-235, 2004. ,
Prognostic factors for survival in adult patients with cerebral low-grade glioma, J Clin Oncol, vol.20, pp.2076-2084, 2002. ,
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials, J Clin Oncol, vol.17, pp.2572-2578, 1999. ,
High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord, Acta Neuropathol, vol.130, pp.435-437, 2015. ,
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity, Acta Neuropathol, vol.131, pp.137-146, 2016. ,
Adult brainstem gliomas: correlation of clinical and molecular features, J Neurol Sci, vol.353, pp.92-97, 2015. ,
Natural history and management of brainstem gliomas in adults: a retrospective Italian study, J Neurol, vol.255, pp.171-177, 2008. ,
ACTR-46. AG120, a first-in-class mutant IDH1 inhibitor in patients with recurrent or progressive IDH1 mutant glioma: results from the phase 1 glioma expansion cohorts, Neuro-Oncol, vol.18, p.12, 2016. ,
Advances and challenges in targeting FGFR signalling in cancer, Nat Rev Cancer, vol.17, pp.318-332, 2017. ,
FGFR1 mutations in rosette-forming glioneuronal tumors of the fourth ventricle, J Neuropathol Exp Neurol, vol.73, pp.580-584, 2014. ,
Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors, Acta Neuropathol, vol.131, pp.847-863, 2016. ,
KIAA1549: BRAF gene fusion and FGFR1 hotspot mutations are prognostic factors in pilocytic astrocytomas, J Neuropathol Exp Neurol, vol.74, pp.743-754, 2015. ,
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma, Nat Genet, vol.45, pp.927-932, 2013. ,
FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers, Histopathology, vol.69, pp.704-707, 2016. ,
Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis, Am J Hum Genet, vol.98, pp.579-587, 2016. ,
Abstract A270: TAS-120, a highly potent and selective irreversible FGFR inhibitor, is effective in tumors harboring various FGFR gene abnormalities, Mol Cancer Ther, vol.12, p.270, 2013. ,
K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway, Neuropathol Appl Neurobiol, vol.43, pp.271-276, 2017. ,
Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours, Neuropathol Appl Neurobiol, vol.41, pp.403-408, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01577983
Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma, Brain Pathol, vol.28, pp.103-111, 2018. ,
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas, J Neurooncol, vol.126, pp.441-446, 2016. ,